Products for Research Use Only
RegisterLogin

Tisagenlecleucel

CAT: 0804-HY-P99338-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99338-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
CAS Number
1823078-37-0
UNSPSC Description
Tisagenlecleucel (CTL019) is an autologous anti-CD19 chimeric antigen receptor (CAR) T-cell therapy. Tisagenlecleucel targets and eliminates CD19-expressing B cells. Tisagenlecleucel can be used for the research of refractory aggressive diffuse large B-cell lymphoma[1][2].
Target Antigen
CD19
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/tisagenlecleucel.html
Solubility
H2O
Smiles
[Tisagenlecleucel]
References & Citations
[1]Bishop MR, et, al. Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma. N Engl J Med. 2022 Feb 17;386(7):629-639. |[2]Fowler NH, et, al. Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial. Nat Med. 2022 Feb;28(2):325-332.
Shipping Conditions
Room temperature
Clinical Information
Launched

Alternative Products

CatalogName
T80981-01Tisagenlecleucel
ICH5928-1mgTisagenlecleucel Biosimilar - Research Grade

Popular Products